| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $28.0M | +417.2% |
| SG&A Expense | $6.0M | +31.8% |
| Operating Income | -$34.1M | -240.6% |
| Interest Expense | $288K | +2518.2% |
| Pre-tax Income | -$35.0M | -229.9% |
| Income Tax | -$116K | +76.2% |
| Net Income | -$34.9M | -244.7% |
| EPS (Basic) | -$67.91 | -96.0% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.3M | -89.2% |
| Current Assets | $1.8M | -85.5% |
| Total Assets | $5.0M | -61.3% |
| Current Liabilities | $7.8M | +194.5% |
| Long-term Debt | $5.2M | — |
| Total Liabilities | $13.0M | +389.7% |
| Stockholders' Equity | -$8.0M | -178.8% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$15.3M | -127.9% |
| Investing Cash Flow | -$656K | -21.5% |
| Financing Cash Flow | $5.4M | -47.0% |